Icade SA
OTC:CDMGF

Watchlist Manager
Icade SA Logo
Icade SA
OTC:CDMGF
Watchlist
Price: 25 USD Market Closed
Market Cap: $1.9B

Icade SA
Investor Relations

In the bustling world of real estate, Icade SA carves out a unique niche as a pivotal player in the French market. Born out of the Caisse des Dépôts conglomerate, Icade is rooted in a tradition of resilience and innovation. The company intricately weaves its operations across three primary areas: property investment, healthcare real estate, and property development. Its property investment arm predominantly deals with office spaces, strategically positioned in major urban hubs like Paris and its environs. This focus allows Icade to benefit from steady rental income, often buoyed by long-term leases to prestigious clients. Meanwhile, its healthcare property segment addresses the ever-growing demand for medical facilities, acquiring and leasing spaces to operators, thereby tapping into a sector that's not only resilient but poised for growth amidst demographic changes.

Complementing these robust investments, Icade's property development division injects dynamism into its portfolio. Here, Icade engages in the creation of new residential and commercial properties, harnessing its expertise to meet the evolving architectural and technological needs of modern living and working spaces. This diversification not only provides Icade with direct revenue streams from sales and leasing but also enhances its asset management prowess, increasing its appeal to investors and stakeholders. In essence, Icade’s business model thrives on a balanced interplay between secure, long-term rental income and the lucrative, albeit more volatile, profits from property development. The company’s strategic diversification within the real estate market underscores a commitment to both stability and growth, ensuring that it remains a formidable force in its domain.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 23, 2025
AI Summary
Q3 2025

Disposals: Icade completed or signed agreements for EUR 430 million in disposals year-to-date, including a significant reduction in healthcare exposure and the sale of non-strategic assets.

Leasing Activity: Strong rental activity with around 166,000 square meters signed or renewed, including a major renewal with KPMG for 41,000 square meters.

Occupancy Improvement: Financial occupancy rate for well-positioned offices rose to 88.8%, up 0.8 points since December 2024; light industrial segment reached 90.4%.

Revenue Decline: Total revenue down 9% year-on-year, with property investment revenue down 6% and property development revenue down 12%.

Development Orders: Development order value fell by 5%, driven by an 11% drop in individual orders, although owner-occupier demand was up 14%.

2025 Guidance Reaffirmed: Net current cash flow guidance for 2025 remains at EUR 3.40–3.60 per share, including EUR 0.67 per share from non-strategic operations.

Outlook Caution: Management remains cautious on 2026 due to tough market conditions, political uncertainty, and subdued recovery expectations.

Key Financials
Disposals Completed or Signed
EUR 430 million
Healthcare Exposure Reduction
EUR 210 million
Disposals of Mature or Non-Strategic Assets
EUR 220 million
Leases Signed or Renewed
166,000 square meters
EQHO Building Lease Renewal
41,000 square meters
Financial Occupancy Rate (Total)
84%
Financial Occupancy Rate (Well-Positioned Offices)
88.8%
Financial Occupancy Rate (Light Industrial)
90.4%
Property Investment Division Revenue
EUR 253 million
Property Development Economic Revenue
EUR 729 million
Development Order Volume
2,815 units, EUR 722 million
Institutional Investor Share of Orders
51% of orders by volume
Annual Rental Income from New Leases
EUR 29 million
Weighted Average Lease Break (WALB)
6.8 years
Net Current Cash Flow Guidance (2025)
EUR 3.40–3.60 per share
Net Current Cash Flow from Nonstrategic Operations (2025 Guidance)
EUR 0.67 per share
Income from Nonstrategic Activities (as of September 2025)
92% of annual target already recorded
Asset Value Decline (H1 2025, Like-for-Like)
-2.8%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Nicolas Joly
Chief Executive Officer
No Bio Available
Ms. Christelle De Robillard
Chief Financial Officer
No Bio Available
Ms. Sophie Duval
Head of Consolidation & Accounting
No Bio Available
Ms. Anne-Violette Faugeras
Director of Financing & Investor Relations
No Bio Available
Ms. Emmanuelle Baboulin
Head of the Commercial Property Investment Division
No Bio Available
Mr. Xavier de La Sudrie
Head of Financial Control
No Bio Available
Johannah Mrejen
Head of Asset Management
No Bio Available
Mr. Guillaume Tessler
Head of International Development - Icade Santé
No Bio Available
Mr. Henri Chapouthier
Head of Sustainable Development
No Bio Available
Cathy Baglin
Head of Employee Affairs
No Bio Available

Contacts

Address
ILE-DE-FRANCE
Issy-les-Moulineaux
Immeuble Open, 27 rue Camille Desmoulins, Cs 10166
Contacts
+33141577000.0
www.icade.fr